{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:40:16Z","timestamp":1782373216749,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The role of adjuvant radiotherapy (RT) for patients with stage III thymoma after complete resection is not definite. Some authors have advocated postoperative RT after complete tumor resection, but some others suggested observation. In this study, we retrospectively evaluated the effect of postoperative RT on survival as well as tumor control in patients with Masaoka stage III thymoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Between June 1982 and December 2010, 65 patients who underwent complete resection of stage III thymoma entered the study. Fifty-three patients had adjuvant RT after surgery (S\u2009+\u2009R) and 12 had surgery only (S alone). Of patients who had adjuvant RT, 28 had three-dimensional conformal RT (3D-CRT)\/intensity modulated RT (IMRT) and 25 had conventional RT. A median prescribed dose of 56 Gy (range, 28\u201360 Gy) was given.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median follow-up time was 50\u00a0months (range, 5\u2013360\u00a0months). Five- and 10-year overall survival (OS) rates were 91.7% and 71.6%, respectively, for S + R and 81.5% and 65.2% for S alone (P\u2009=\u20090.5), respectively. In the subgroup analysis, patients with 3D-CRT\/IMRT showed a trend of improved 5-year OS rate compared with conventional RT (100% vs. 86.9%, P =0.12). Compared with S alone, the 5-year OS rate was significantly improved (100% vs. 81.5%, P\u2009=\u20090.049). Relapses occurred in 15 patients (23.1%). There was a trend of lower crude local recurrence rates for S\u2009+\u2009R (3.8%) compared with S alone (16.7%) (P\u2009=\u20090.09), whereas the crude regional recurrence rates were similar (P\u2009=\u20090.9). No clear dose\u2013response relationship was found according to prescribed doses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Adjuvant 3D-CRT\/IMRT showed potential advantages in improving survival and reducing relapse in patients with stage III thymoma after complete resection, whereas adjuvant RT did not significantly improve survival or reduce recurrence for the cohort as a whole. Doses of \u2264\u200950 Gy may be effective and could be prescribed for adjuvant RT. To confirm the role of adjuvant 3D-CRT\/IMRT in patients who undergo a complete resection of thymoma, a multicenter randomized study should be performed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-8-199","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T04:49:09Z","timestamp":1376369349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution"],"prefix":"10.1186","volume":"8","author":[{"given":"Chengcheng","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouguang","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jima","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,13]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/0003-4975(95)00669-C","volume":"60","author":"D Blumberg","year":"1995","unstructured":"Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, Ginsberg RJ, Martini N, McCormack PM, Rusch V, et al.: Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995, 60: 908-913. discussion 914 10.1016\/0003-4975(95)00669-C","journal-title":"Ann Thorac Surg"},{"key":"926_CR2","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","volume":"6","author":"WJ Curran Jr","year":"1988","unstructured":"Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd: Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988, 6: 1722-1727.","journal-title":"J Clin Oncol"},{"key":"926_CR3","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1200\/JCO.1994.12.7.1484","volume":"12","author":"IF Ciernik","year":"1994","unstructured":"Ciernik IF, Meier U, Lutolf UM: Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994, 12: 1484-1490.","journal-title":"J Clin Oncol"},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.ijrobp.2009.09.066","volume":"78","author":"YD Chen","year":"2010","unstructured":"Chen YD, Feng QF, Lu HZ, Mao YS, Zhou ZM, Ou GF, Wang M, Zhao J, Zhang HX, Xiao ZF, et al.: Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection. Int J Radiat Oncol Biol Phys 2010, 78: 1400-1406. 10.1016\/j.ijrobp.2009.09.066","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"926_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0003-4975(95)00983-3","volume":"61","author":"K Yagi","year":"1996","unstructured":"Yagi K, Hirata T, Fukuse T, Yokomise H, Inui K, Ike O, Mizuno H, Aoki M, Hitomi S, Wada H: Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. Ann Thorac Surg 1996, 61: 521-524. 10.1016\/0003-4975(95)00983-3","journal-title":"Ann Thorac Surg"},{"key":"926_CR6","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981, 48: 2485-2492. 10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","journal-title":"Cancer"},{"key":"926_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","volume":"44","author":"K Koga","year":"1994","unstructured":"Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T, Shimosato Y: A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994, 44: 359-367.","journal-title":"Pathol Int"},{"key":"926_CR8","first-page":"146","volume-title":"Tumors of Thymus","author":"W Travis","year":"2004","unstructured":"Travis W, Brambilla E, Mueller-Hermelink H, Harris C: World Health classification of tumours.Pathologe and genetics of tumours of the lung, pleura, thymus and heart. In Tumors of Thymus. Edited by: Muller-Hermelink HK. Lyon: IARC Press; 2004:146-248."},{"key":"926_CR9","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1111\/j.1440-0960.2011.00818.x","volume":"54","author":"T Miyagaki","year":"2013","unstructured":"Miyagaki T, Sugaya M, Miyamoto A, Nagata M, Ichimura Y, Mitsui H, Sato S: Oral erosive lichen planus associated with thymoma treated with etretinate. Australas J Dermatol 2013, 54: e25-e27. 10.1111\/j.1440-0960.2011.00818.x","journal-title":"Australas J Dermatol"},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T","volume":"74","author":"L Quintanilla-Martinez","year":"1994","unstructured":"Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL: Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994, 74: 606-617. 10.1002\/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T","journal-title":"Cancer"},{"key":"926_CR11","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, Gold R, Semik M, Kiefer R, Nix W, et al.: Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004, 22: 1501-1509. 10.1200\/JCO.2004.10.113","journal-title":"J Clin Oncol"},{"key":"926_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","volume":"76","author":"K Kondo","year":"2003","unstructured":"Kondo K, Monden Y: Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003, 76: 878-884. discussion 884\u2013875 10.1016\/S0003-4975(03)00555-1","journal-title":"Ann Thorac Surg"},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0360-3016(99)00514-3","volume":"46","author":"M Myojin","year":"2000","unstructured":"Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, et al.: Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 2000, 46: 927-933. 10.1016\/S0360-3016(99)00514-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1081\/CNV-120023772","volume":"21","author":"Y Eralp","year":"2003","unstructured":"Eralp Y, Aydiner A, Kizir A: Resectable thymoma:treatment outcome and prognostic factors in late adolescent and adult age group. Cancer Invest 2003, 21: 37-43.","journal-title":"Cancer Invest"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0022-5223(97)70399-4","volume":"113","author":"E Ruffini","year":"1997","unstructured":"Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavallo A, Cianci R, Filosso PL, Molinatti M, Porrello C, Cappello N, Maggi G: Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 1997, 113: 55-63. 10.1016\/S0022-5223(97)70399-4","journal-title":"J Thorac Cardiovasc Surg"},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.athoracsur.2008.11.022","volume":"87","author":"RJ Korst","year":"2009","unstructured":"Korst RJ, Kansler AL, Christos PJ, Mandal S: Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 2009, 87: 1641-1647. 10.1016\/j.athoracsur.2008.11.022","journal-title":"Ann Thorac Surg"},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00000658-199608000-00016","volume":"224","author":"M Haniuda","year":"1996","unstructured":"Haniuda M, Miyazawa M, Yoshida K, Oguchi M, Sakai F, Izuno I, Sone S: Is postoperative radiotherapy for thymoma effective? Ann Surg 1996, 224: 219-224. 10.1097\/00000658-199608000-00016","journal-title":"Ann Surg"},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.ijrobp.2011.03.010","volume":"82","author":"S Patel","year":"2012","unstructured":"Patel S, Macdonald OK, Nagda S, Bittner N, Suntharalingam M: Evaluation of the role of radiation therapy in the management of malignant Thymoma. Int J Radiat Oncol Biol Phys 2012, 82: 1797-1801. 10.1016\/j.ijrobp.2011.03.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ijrobp.2004.05.013","volume":"60","author":"G Zhu","year":"2004","unstructured":"Zhu G, He S, Fu X, Jiang G, Liu T: Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients. Int J Radiat Oncol Biol Phys 2004, 60: 1113-1119. 10.1016\/j.ijrobp.2004.05.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0167-8140(94)01493-M","volume":"34","author":"D Cowen","year":"1995","unstructured":"Cowen D, Richaud P, Mornex F, Bachelot T, Jung GM, Mirabel X, Marchal C, Lagrange JL, Rambert P, Chaplain G, et al.: Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation nationale des centres de lutte contre le cancer. Radiother Oncol 1995, 34: 9-16. 10.1016\/0167-8140(94)01493-M","journal-title":"Radiother Oncol"},{"key":"926_CR21","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/JTO.0b013e3182745f73","volume":"7","author":"T Harnath","year":"2012","unstructured":"Harnath T, Marx A, Strobel P, Bolke E, Willers R, Gripp S: Thymoma-a clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose. J Thorac Oncol 2012, 7: 1867-1871. 10.1097\/JTO.0b013e3182745f73","journal-title":"J Thorac Oncol"},{"key":"926_CR22","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/cncr.10373","volume":"94","author":"K Ogawa","year":"2002","unstructured":"Ogawa K, Uno T, Toita T, Onishi H, Yoshida H, Kakinohana Y, Adachi G, Itami J, Ito H, Murayama S: Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 2002, 94: 1405-1413. 10.1002\/cncr.10373","journal-title":"Cancer"},{"key":"926_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/COC.0b013e318042d566","volume":"30","author":"Y Kundel","year":"2007","unstructured":"Kundel Y, Yellin A, Popovtzer A, Pfeffer R, Symon Z, Simansky DA, Oberman B, Sadezki S, Brenner B, Catane R, Levitt ML: Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. Am J Clin Oncol 2007, 30: 389-394. 10.1097\/COC.0b013e318042d566","journal-title":"Am J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-8-199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:57:15Z","timestamp":1630544235000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-8-199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,13]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-8-199","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,13]]},"assertion":[{"value":"24 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"199"}}